A 68-year-old with HFrEF (LVEF 30%) is on ACE inhibitor, beta-blocker and spironolactone. Symptoms persist (NYHA II). What additional disease-modifyin...

Question

A 68-year-old with HFrEF (LVEF 30%) is on ACE inhibitor, beta-blocker and spironolactone. Symptoms persist (NYHA II). What additional disease-modifying therapy is recommended?

Accepted Answer

Add SGLT2 inhibitor (e.g., dapagliflozin)

Answer

Add ivabradine for all

Answer

Add loop diuretic only

Answer

Add hydralazine alone

Answer

Stop spironolactone

ukmla MCQ (SBA): Heart Failure with Reduced EF

A 68-year-old with HFrEF (LVEF 30%) is on ACE inhibitor, beta-blocker and spironolactone. Symptoms persist (NYHA II). What additional disease-modifying therapy is recommended?